<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  <BR>                     Information for Patients <BR>                  <BR>                  <BR>                     <BR>                        Pregnancy<BR>                     <BR>                  <BR>                  Letrozole tablets are contraindicated in women of premenopausal endocrine <BR>status. The physician needs to discuss the necessity of adequate contraception <BR>with women who have the potential to become pregnant including women who are <BR>perimenopausal or who recently became postmenopausal, until their postmenopausal <BR>status is fully established. <BR>                  <BR>                     <BR>                        Fatigue and Dizziness<BR>                     <BR>                  <BR>                  Since fatigue and dizziness have been observed with the use of letrozole and <BR>somnolence was uncommonly reported, caution is advised when driving or using <BR>machinery. <BR>                  <BR>                     <BR>                        Bone Effects<BR>                     <BR>                  <BR>                  Consideration should be given to monitoring bone mineral density. <BR>                  <BR>                     <BR><BR>                  <BR>                  Mylan Pharmaceuticals Inc.<BR>Morgantown, WV 26505 U.S.A.<BR>                  REVISED DECEMBER 2010<BR>LETR:R2<BR>                  <BR><BR>                  <BR>                     <BR><BR>                  <BR>                  <BR>                     Relabeling of "Additional" label by:<BR>                     <BR>Physicians Total Care, Inc.<BR>Tulsa, OK        74146<BR><BR>                  <BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>